NASAL LACRIMAL STENT MARKET ANALYSIS
A nasolacrimal stent is considered to be a small tube used to treat conditions like epiphora and intended for use in dacryocystorhinostomy (DCR) and congenital nasolacrimal obstruction as well. Growing prevalence of nasolacrimal duct obstruction (NLDO), a common syndrome of lacrimal system, is expected to drive growth of nasal lacrimal stent market. For instance, in 2019, according to data published by the NCBI (National Center for Biotechnology Information), the prevalence for nasolacrimal duct obstruction has found around 6% to 20% in global infants.
Market- Trends
The nasal lacrimal stent market size is expected to increase over the forecast period owing to ongoing research on products to treat Epiphora and Dacryocystorhinostomy disease conditions. For instance, October 2019, Alon Kahana from University of Michigan sponsored a study aimed to evaluate safety and efficacy of the slit stent ii lacrimal stent for treatment of nasolacrimal duct obstruction.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
